Loading…
Susceptibility of Candida albicans Isolated from Blood to Wickerhamomyces anomalous Mycocins
The occurrence of infections caused by Candida albicans in developed and developing countries and their resistance to some available antifungal drugs have been viewed as causing a great problem to human health worldwide. In order to find new researched molecules, there are some mycoses secreted by y...
Saved in:
Published in: | Current microbiology 2016-12, Vol.73 (6), p.878-884 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The occurrence of infections caused by
Candida albicans
in developed and developing countries and their resistance to some available antifungal drugs have been viewed as causing a great problem to human health worldwide. In order to find new researched molecules, there are some mycoses secreted by yeasts, especially mycocins produced by
Wickerhamomyces anomalus
with a broad antimicrobial spectrum of activity. Thus, this trial aimed at evaluating mycocins’ activity obtained from environmental
W. anomalus
cell wall compared to thirty
C. albicans
strains isolated from blood. Mycocins were extracted from cell walls of three
W. anomalus
strains (WA40, WA45, and WA92). The 400 μg mL
−1
concentration of WA40M1, WA45M2, and WA92M3 mycocin extracts showed the following respective activity results: 96.6, 96.6, and 90.0 %
C. albicans
strains. WA45M2 and WA92M3 mycocin extracts showed some activity in 3.3 % of
C. albicans
strains at 50 μg mL
−1
concentration. Mycocins extracted from cell walls of three
W. anomalus
strains named as WA40, WA45, and WA92 showed antifungal activity compared to
C. albicans
and low degree of hemolysis. |
---|---|
ISSN: | 0343-8651 1432-0991 |
DOI: | 10.1007/s00284-016-1135-4 |